1
Ble myosepta boundaries.ISRN Molecular Biology475 Length (m) Length (m) Uninjected4501400 Empty 95?8 kcnj2-12 WT kcnj2-12 95?8/WT kcnj2-0 Uninjected Empty 95?8 kcnj2-12 WT kcnj2-12 95?8/WT kcnj2-(a)(b)550 525 500 Length (m) 475 75 50 25 0 Uninjected EmptyWT kcnj2-(c)Figure 4: The average measurements of morphological features of 6 dpf embryos over-expressing 95?8 kcnj2-12, WT kcnj2-12, and combin
1
Perties and molecular mechanisms. J. Control. Release 2015, 201, 1?3. 145. Harde, H.; Das, M.; Jain, S. Solid lipid nanoparticles: An oral bioavailability enhancer vehicle. Expert Opin. Drug Deliv. 2011, 8, 1407?424. 146. Parhi, R.; Suresh, P. Preparation and characterization of solid lipid nanoparticles--A review. Curr. Drug Discov. Technol. 2012, 9, 2?6. 147. Machado, A.H.E.; Lundberg, D.; Ribei